Palomino Laboratories (PALX) Payables (2022 - 2025)
Palomino Laboratories recorded quarterly Payables of $55687.0 in Q4 2025, down 8.64% quarter-over-quarter from $60952.0 in Q3 2025, and up 765.92% year-over-year from $6431.0 in Q4 2024.
Palomino Laboratories' Payables history runs 4 years deep, the most recent figure standing at $55687.0 for Q4 2025.
- In Q4 2025, Payables rose 765.92% year-over-year to $55687.0; the TTM figure through Dec 2025 stood at $55687.0 (up 765.92% YoY), while the FY2025 annual figure was $55687.0, up 765.92% from the prior year.
- Payables came in at $55687.0 for Q4 2025 at Palomino Laboratories, down from $60952.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $177004.0 in Q3 2024 to a low of $6431.0 in Q4 2024.
- A 4-year average of $63031.8 and a median of $55687.0 in 2025 frame the typical range for Payables.
- On a YoY basis, Payables climbed as much as 765.92% in 2025 and fell as far as 65.56% in 2025.
- Palomino Laboratories' Payables stood at $12804.0 in 2022, then declined by 21.45% to $10058.0 in 2023, then sank by 36.06% to $6431.0 in 2024, then surged by 765.92% to $55687.0 in 2025.
- According to Business Quant data, Payables over the past three periods registered $55687.0, $60952.0, and $60781.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,687.00 |
| Sep 30, 2025 | 60,952.00 |
| Jun 30, 2025 | 60,781.00 |
| Mar 31, 2025 | 320,816.00 |
| Dec 31, 2024 | 6,431.00 |
| Sep 30, 2024 | 177,004.00 |
| Jun 30, 2024 | 154,158.00 |
| Mar 31, 2024 | 126,675.00 |
| Dec 31, 2023 | 10,058.00 |
| Sep 30, 2023 | 51,297.00 |
| Dec 31, 2022 | 17,500.00 |